Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Síndrome de piernas inquietas

138 ARTíCULOS , VIENDO DEL 1 AL 15

PUBMED

Gabapentin enacarbil (XP13512/GSK1838262) as an alternative treatment to dopaminergic agents for restless legs syndrome.

Imamura S, Kushida C.

Expert Opin Pharmacother. 2010 Aug;11(11):1925-32. doi: 10.1517/14656566.2010.494598. Review.

0

0

0

PUBMED

Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study.

Garcia-Borreguero D, Larrosa O, Williams AM, Albares J, Pascual M, Palacios JC, Fernandez C.

Neurology. 2010 Jun 8;74(23):1897-904. doi: 10.1212/WNL.0b013e3181e1ce73.

0

0

0

PUBMED

Compulsive habits in restless legs syndrome patients under dopaminergic treatment.

Pourcher E, Rémillard S, Cohen H.

J Neurol Sci. 2010 Mar 15;290(1-2):52-6. doi: 10.1016/j.jns.2009.11.010.

0

0

0

PUBMED

Restless legs syndrome: a unique case of relapse after traffic accidents with a long remission.

Kakisaka Y, Haginoya K, Uematsu M, Tsuchiya S.

Sleep Med. 2010 Jun;11(6):596-7. doi: 10.1016/j.sleep.2010.02.005. No abstract available.

0

0

0

PUBMED

Restless legs syndrome and periodic limb movements disorder in the pediatric population.

Khatwa U, Kothare SV.

Curr Opin Pulm Med. 2010 Nov;16(6):559-67. doi: 10.1097/MCP.0b013e32833f11ae. Review.

0

0

0

PUBMED

Restless legs syndrome and its relationship with anxiety, depression, and quality of life in cancer patients undergoing chemotherapy.

Ostacoli L, Saini A, Ferini-Strambi L, Castronovo V, Sguazzotti E, Picci RL, Toje M, Gorzegno G, Capogna S, Dongiovanni V, Dogliotti L, Furlan PM, Berruti A.

Qual Life Res. 2010 May;19(4):531-7. doi: 10.1007/s11136-010-9614-8.

0

0

0

PUBMED

Crohn's disease is associated with restless legs syndrome.

Weinstock LB, Bosworth BP, Scherl EJ, Li E, Iroku U, Munsell MA, Mullin GE, Walters AS.

Inflamm Bowel Dis. 2010 Feb;16(2):275-9. doi: 10.1002/ibd.20992. Erratum in: Inflamm Bowel Dis. 2014 Aug;20(8):1471. Mullen, Gerald E [corrected to Mullin, Gerard E].

0

0

0

PUBMED

A further cause of secondary restless legs syndrome: Crohn's disease.

Gemignani F.

Inflamm Bowel Dis. 2010 Feb;16(2):280-1. doi: 10.1002/ibd.21093. No abstract available.

0

0

0

PUBMED

Long-term open-label study of pramipexole in patients with primary restless legs syndrome.

Inoue Y, Kuroda K, Hirata K, Uchimura N, Kagimura T, Shimizu T.

J Neurol Sci. 2010 Jul 15;294(1-2):62-6. doi: 10.1016/j.jns.2010.04.003.

0

0

0

PUBMED

Restless legs syndrome: pathophysiology, clinical presentation and management.

Trenkwalder C, Paulus W.

Nat Rev Neurol. 2010 Jun;6(6):337-46. doi: 10.1038/nrneurol.2010.55. Review.

0

0

0

PUBMED

Normal regional brain iron concentration in restless legs syndrome measured by MRI.

Knake S, Heverhagen JT, Menzler K, Keil B, Oertel WH, Stiasny-Kolster K.

Nat Sci Sleep. 2009 Dec 22;2:19-22.

0

0

0

PUBMED

Randomized trials of dopamine agonists in restless legs syndrome: a systematic review, quality assessment, and meta-analysis.

Zintzaras E, Kitsios GD, Papathanasiou AA, Konitsiotis S, Miligkos M, Rodopoulou P, Hadjigeorgiou GM.

Clin Ther. 2010 Feb;32(2):221-37. doi: 10.1016/j.clinthera.2010.01.028. Review.

0

0

0

PUBMED

Drug-induced restless legs syndrome.

[No authors listed]

Prescrire Int. 2010 Aug;19(108):164-5.

0

0

0

PUBMED

Restless legs syndrome associated with narcolepsy and somnambulism.

Alonso-Navarro H, Jiménez-Jiménez FJ.

Parkinsonism Relat Disord. 2010 Feb;16(2):146-7. doi: 10.1016/j.parkreldis.2009.08.002. No abstract available.

0

0

0

PUBMED

Treatment of restless legs syndrome in patients with chronic kidney disease: a focus on medications.

Raymond CB, Breland L, Wazny LD, Sood AR, Orsulak CD.

CANNT J. 2010 Apr-Jun;20(2):29-33; quiz 34-5. No abstract available.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy